guanethidine has been researched along with Atrial Septal Defect in 1 studies
Guanethidine: An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues.
guanethidine : A member of the class of guanidines in which one of the hydrogens of the amino group has been replaced by a 2-azocan-1-ylethyl group.
guanethidine sulfate : A organic sulfate salt composed of two molecules of guanethidine and one of sulfuric acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cudkowicz, L | 1 |
1 other study available for guanethidine and Atrial Septal Defect
| Article | Year |
|---|---|
Normal, pharmacological and disordered systemic circulatory responses to the Valsalva manoeuvre.
Topics: Adult; Aged; Aortic Valve Insufficiency; Atrial Function; Blood Pressure; Emphysema; Guanethidine; H | 1968 |